Given EMP3’s emerging role in the tumor immune microenvironment [12] and its high expression in both GBM and tumor-infiltrating macrophages and T cells [46], it would be interesting to investigate how its membrane interactions and/or receptor trafficking function could ultimately influence cancer cell-immune cell crosstalk in GBM. The gene discussed is EMP3; the disease is cancer.